BEGIN:VCALENDAR
CALSCALE:GREGORIAN
VERSION:2.0
METHOD:PUBLISH
PRODID:explore_courses
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTEND;TZID=America/Los_Angeles:20170111T193000
LAST-MODIFIED:20170109T213856
UID:explore_courses9844bf7b-2efc-4455-8ea4-1041af520d2d
DTSTAMP:20170109T213856
LOCATION:
DESCRIPTION:Advancing a drug from discovery of a therapeutic target to human trials and commercialization. Topics include: high throughput assay development, compound screening, lead optimization, protecting intellectual property, toxicology testing, regulatory issues, assessment of clinical need, defining the market, conducting clinical trials, project management, and commercialization issues, including approach to licensing and raising capital.  Maximum units are available by taking an additional contact hour.
STATUS:CONFIRMED
SEQUENCE:0
SUMMARY:CSB240A LEC
DTSTART;TZID=America/Los_Angeles:20170111T173000
CREATED:20170109T213856
RRULE:FREQ=WEEKLY;INTERVAL=1;UNTIL=20170317T193000;BYDAY=WE
END:VEVENT
BEGIN:VEVENT
DTEND;TZID=America/Los_Angeles:20170113T122000
LAST-MODIFIED:20170109T213856
UID:explore_courses6070eac8-9708-441e-b972-7b16064f8039
DTSTAMP:20170109T213856
LOCATION:Li Ka Shing Center, room 209
DESCRIPTION:Advancing a drug from discovery of a therapeutic target to human trials and commercialization. Topics include: high throughput assay development, compound screening, lead optimization, protecting intellectual property, toxicology testing, regulatory issues, assessment of clinical need, defining the market, conducting clinical trials, project management, and commercialization issues, including approach to licensing and raising capital.  Maximum units are available by taking an additional contact hour.
STATUS:CONFIRMED
SEQUENCE:0
SUMMARY:CSB240A LEC
DTSTART;TZID=America/Los_Angeles:20170113T103000
CREATED:20170109T213856
RRULE:FREQ=WEEKLY;INTERVAL=1;UNTIL=20170317T122000;BYDAY=FR
END:VEVENT
END:VCALENDAR